Murray Cod Australia (ASX: MCA) has successfully completed the institutional component of its accelerated non-renounceable entitlement offer.
The company raised approximately $10.1 million by issuing approximately 67.2 million new shares at an issue price of $0.15 per share.
The institutional take-up rate for the offer was approximately 67.59%.
The broader capital raise is a 1-for-1 fully underwritten accelerated non-renounceable entitlement offer expected to generate total gross proceeds of approximately $18.6 million.
The retail component of the offer is scheduled to open on 8 May 2026 and close on 20 May 2026.
Strategic Rationale and Use of Funds
The capital raise is primarily aimed at funding working capital to support the conversion of 3,700 tonnes of saleable biomass into cash.
Approximately $15.9 million has been earmarked for this purpose, alongside $0.8 million for growth capital to expand processing capacity and product formats.
Additionally, approximately $0.4 million is allocated for restructuring and rightsizing costs, with $1.5 million covering the costs of the offer.
The company's refreshed strategy, driven by new leadership including chief executive officer Steven Chaur, focuses on a customer-led, multi-channel domestic sales approach.
Dilution and Control Implications
Upon completion, the offer is expected to result in the issuance of approximately 123.9 million new shares, representing about 50% of the company's post-completion shares.
As the rights are non-renounceable, eligible shareholders who do not participate will experience dilution.
Major shareholder Regal Funds Management and chair Brett Paton have committed to taking up their full entitlements in the institutional component and sub-underwriting up to $4.0 million each.
This could potentially increase Regal's maximum voting power to 27.03% and Paton's to 15.45%, depending on the overall take-up and shortfall outcomes.
Outlook and Key Considerations
Murray Cod Australia has secured significant capital through its institutional entitlement offer, which is crucial for monetising its substantial biomass.
Investors will be watching retail take-up and the company's execution of its revised sales strategy to convert this biomass into revenue.
They will also be assessing the impact of dilution and potential shifts in shareholder control.
